Economics Faculty Database
Economics
Arts & Sciences
Duke University

 HOME > Arts & Sciences > Economics > Faculty    Search Help Login pdf version printable version 

David B. Ridley, Professor of the Practice of Business Adminstration

David B. Ridley

David Ridley is the Faculty Director for Health Sector Management at Duke University’s Fuqua School of Business. He studies health care innovation, production, and prices. He is especially interested in how to encourage development of drugs and vaccines for neglected diseases. David was the lead author of the paper proposing the priority review voucher program which became law and created a market of more than a billion dollars to encourage drug development for neglected diseases. His research has been funded by the Bill & Melinda Gates Foundation and the National Institutes of Health. David teaches courses on health care policy and strategy to Duke University graduate students. He received a doctorate in economics from Duke University.

Contact Info:
Office Location:  100 Fuqua Drive, Durham, NC 27708-0120
Email Address: send me a message
Web Pages:  http://www.fuqua.duke.edu/faculty/david-ridley
https://sites.duke.edu/ridley/

Teaching (Fall 2022):

  • HLTHMGMT 718E.601, LIFE SCIENCE STRATEGY Synopsis
    TBA, Sat 01:00 AM-02:00 AM
  • QM 724QH.101, HEALTHCAREINSTITUTIONS&POLICY1 Synopsis
    TBA, -
Education:

Ph.D.Duke University2001
M.A.Duke University1995
B.A.University of Missouri, Columbia1993
Specialties:

Health Economics
Industrial Organization
Research Interests:

David Ridley is the Dr. and Mrs. Frank A. Riddick Professor of the Practice of Business. He is also the Faculty Director of Duke's Health Sector Management program. In his research, David examines innovation and pricing, especially in health care. He was the lead author of the paper proposing the priority review voucher program The voucher program became law in the U.S. in 2007 and the market price of vouchers has been more than $100 million. David has published in economics journals (American Economic Journal: Economic Policy), medical journals (Journal of the American Medical Association), and scientific journals (Nature Reviews Drug Discovery). David teaches in the daytime MBA and executive MBA programs. He received a PhD in economics from Duke University in 2001.

Areas of Interest:

Health Economics
Industrial Organization
Strategy

Keywords:

Biotechnology • Drug Approval • Drug Costs • Drug Industry • Economics, Pharmaceutical • Elasticity • Health Care Costs • Health Care Economics and Organizations • Health Care Reform • Health Care Sector • Health Policy • Health Services Research • Innovation • Market entry • Patents as Topic • Prescription Fees • Pricing • Product Surveillance, Postmarketing • World Health Organization

Curriculum Vitae
Recent Publications   (More Publications)   (search)

  1. Ridley, DB; Ganapathy, P; Kettler, HE, ​US Tropical Disease Priority Review Vouchers: Lessons In Promoting Drug Development And Access., Health Affairs, vol. 40 no. 8 (August, 2021), pp. 1243-1251 [doi]  [abs]
  2. Ridley, DB; Lee, CY, Does medicare reimbursement drive up drug launch prices?, The Review of Economics and Statistics, vol. 102 no. 5 (December, 2020), pp. 980-993 [doi]  [abs]
  3. Kyle, MK; Ridley, DB; Zhang, S, Strategic interaction among governments in the provision of a global public good, Journal of Public Economics, vol. 156 (December, 2017), pp. 185-199, Elsevier BV [doi]  [abs]
  4. Ridley, DB; Moe, JL; Hamon, N, A Voucher System To Speed Review Could Promote A New Generation Of Insecticides To Fight Vector-Borne Diseases., Health Affairs, vol. 36 no. 8 (August, 2017), pp. 1461-1468 [doi]  [abs]
  5. Yurukoglu, A; Liebman, E; Ridley, DB, The role of government reimbursement in drug shortages, American Economic Journal: Economic Policy, vol. 9 no. 2 (May, 2017), pp. 348-382, American Economic Association [doi]  [abs]


Duke University * Arts & Sciences * Economics * Faculty * Research * Staff * Master's * Ph.D. * Reload * Login